Ascentage Pharma Group International
AAPG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002023311
No open-market purchases or sales by Ascentage Pharma Group International insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $263.5K in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Ascentage Pharma Group International changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 0 | 6 | +6 |
| Shares | 0 | 237.2K | +237.2K |
| Value | $0 | $5.21M | +$5.21M |
New holders (6)
Institutions that held Ascentage Pharma Group International at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Monashee Investment Management LLC | 159,942 | $3.51M | 0.42% |
| Point72 (DIFC) Ltd | 25,404 | $557.6K | 0.05% |
| XY Capital Ltd | 23,505 | $515.9K | 0.34% |
| Voloridge Investment Management, LLC | 15,943 | $349.9K | 0.00% |
| Verition Fund Management LLC | 9,922 | $217.8K | 0.00% |
| UBS Group AG | 2,478 | $54.4K | 0.00% |
Sold out (0)
Institutions that held Ascentage Pharma Group International at the end of Q4 2024 and filed for Q1 2025 without it.
None.